Kanayama Y, Shiota K, Horiguchi T, Kato N, Ohe A, Inoue T
Arch Intern Med. 1981 Aug;141(9):1176-9.
Examination of 27 patients with systemic lupus erythematosus (SLE) before treatment showed an elevation of the serum level of lactic dehydrogenase (LDH) in 15 patients. In these patients, the LDH level fell to normal in response to corticosteroid therapy. In six of 27 patients, steroid myopathy with elevation of the LDH level developed during corticosteroid therapy. At the same time, there was no or only a slight increase in the creatine phosphokinase level, while the SGOT and aldolase levels remained normal. The elevated LDH levels gradually returned to normal as the corticosteroid dosages were reduced and the myopathic symptoms disappeared. We suggest that the measurement of LDH levels is useful for diagnosis and the subsequent treatment of patients with steroid myopathy in SLE.
对27例系统性红斑狼疮(SLE)患者治疗前的检查显示,15例患者血清乳酸脱氢酶(LDH)水平升高。在这些患者中,皮质类固醇治疗后LDH水平降至正常。27例患者中有6例在皮质类固醇治疗期间出现了伴有LDH水平升高的类固醇肌病。与此同时,肌酸磷酸激酶水平无升高或仅略有升高,而谷草转氨酶和醛缩酶水平保持正常。随着皮质类固醇剂量的减少和肌病症状消失,升高的LDH水平逐渐恢复正常。我们认为,测定LDH水平有助于诊断和后续治疗SLE患者的类固醇肌病。